Kimme L Hyrich Selected Research

Inflammation (Inflammations)

11/2022	Exploring the disparity between inflammation and disability in the 10-year outcomes of people with rheumatoid arthritis.
11/2022	Pre-defined gene co-expression modules in rheumatoid arthritis transition towards molecular health following anti-TNF therapy.
1/2016	Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis.
1/2011	Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kimme L Hyrich Research Topics

Disease

86	Rheumatoid Arthritis 05/2024 - 01/2005
28	Necrosis 12/2023 - 01/2009
21	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 03/2024 - 01/2010
13	Arthritis (Polyarthritis) 01/2024 - 01/2010
13	COVID-19 08/2023 - 01/2021
12	Rheumatic Diseases (Rheumatism) 11/2022 - 08/2012
8	Infections 09/2023 - 01/2011
7	Psoriatic Arthritis 01/2023 - 01/2009
6	Neoplasms (Cancer) 01/2023 - 01/2013
5	Uveitis 07/2023 - 05/2016
5	Joint Diseases (Joint Disease) 01/2022 - 11/2008
4	Vasculitis (Vasculitides) 08/2023 - 01/2017
4	Inflammation (Inflammations) 11/2022 - 01/2011
3	Tuberculosis (Tuberculoses) 09/2023 - 11/2019
3	Pain (Aches) 11/2022 - 01/2018
3	Musculoskeletal Diseases (Musculoskeletal Disease) 11/2022 - 01/2022
2	Connective Tissue Diseases (Connective Tissue Disease) 08/2023 - 01/2022
2	Giant Cell Arteritis (Horton Disease) 01/2023 - 12/2021
2	Fatigue 11/2022 - 12/2018
2	Drug-Related Side Effects and Adverse Reactions 01/2022 - 03/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2021
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Obesity 12/2021 - 06/2020
2	Lymphoma (Lymphomas) 03/2017 - 01/2017
2	Melanoma (Melanoma, Malignant) 02/2017 - 10/2016
2	Myocardial Infarction 01/2017 - 11/2010
2	Anterior Uveitis 01/2016 - 01/2011
1	Cytokine Release Syndrome 01/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023
1	Neuromyelitis Optica (Devic's Disease) 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Adult-Onset Still's Disease 01/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023
1	Castleman Disease (Castleman's Disease) 01/2023
1	Hepatitis B 01/2023
1	Hepatitis C 01/2023
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2023
1	Latent Tuberculosis 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 10/2022
1	Disease Progression 10/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Breakthrough Infections 01/2022

Drug/Important Bio-Agent (IBA)

34	Antirheumatic Agents (DMARD)IBA 05/2024 - 06/2006
20	Methotrexate (Mexate)FDA LinkGeneric 01/2024 - 06/2006
18	Tumor Necrosis Factor InhibitorsIBA 03/2024 - 04/2015
18	Etanercept (Enbrel)FDA Link 12/2023 - 06/2006
16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2024 - 01/2005
12	Adalimumab (Humira)FDA Link 12/2023 - 01/2009
12	GlucocorticoidsIBA 08/2023 - 12/2018
12	Rituximab (Mabthera)FDA Link 01/2023 - 02/2012
8	Infliximab (Remicade)FDA Link 01/2023 - 06/2006
8	ametantrone (HAQ)IBA 11/2022 - 01/2010
6	Janus Kinase InhibitorsIBA 05/2024 - 01/2021
5	Biomarkers (Surrogate Marker)IBA 06/2023 - 01/2016
5	tocilizumab (atlizumab)FDA Link 01/2023 - 02/2017
4	Abatacept (Orencia)FDA Link 01/2023 - 03/2012
4	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 01/2021
3	Rheumatoid FactorIBA 01/2024 - 01/2018
3	tofacitinibIBA 12/2023 - 01/2022
3	VaccinesIBA 01/2023 - 01/2022
3	C-Reactive ProteinIBA 01/2023 - 10/2012
3	AntibodiesIBA 01/2017 - 02/2015
2	Biosimilar PharmaceuticalsIBA 12/2023 - 01/2023
2	HLA-DRB1 Chains (HLA DRB1)IBA 09/2023 - 04/2015
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 08/2023 - 01/2023
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023 - 01/2022
2	upadacitinibIBA 01/2023 - 01/2022
2	ORALIT (ORS)IBA 01/2023 - 12/2021
2	GLPG0634IBA 01/2023 - 01/2022
2	Certolizumab Pegol FDA Link 01/2023 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2023 - 09/2015
2	baricitinibIBA 01/2023 - 01/2022
2	Immunomodulating AgentsIBA 10/2022 - 10/2021
2	Prednisone (Sone)FDA LinkGeneric 01/2022 - 12/2018
2	Oxygen (Dioxygen)IBA 12/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2012
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2019 - 07/2011
1	Antinuclear AntibodiesIBA 01/2024
1	HLA-DQA1 antigen (HLA DQA1)IBA 09/2023
1	Leflunomide (Arava)FDA LinkGeneric 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	golimumab FDA Link 01/2023
1	BNT162 VaccineIBA 01/2023
1	sarilumabIBA 01/2023
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	ChAdOx1 nCoV-19IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	AutoantibodiesIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Tuberculin (PPD)IBA 11/2022
1	Interferon-gamma (Interferon, gamma)IBA 11/2022
1	Monoclonal AntibodiesIBA 10/2022
1	Interleukin-6 InhibitorsIBA 10/2022
1	COVID-19 VaccinesIBA 01/2022

Therapy/Procedure

55	Therapeutics 09/2023 - 01/2009
16	Biological Therapy 01/2023 - 01/2005
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2016
2	Precision Medicine 07/2023 - 01/2023